Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYXR.L Regulatory News (MYXR)

  • There is currently no data for MYXR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Meeting Statement

19 May 2015 07:00

RNS Number : 5727N
MyCelx Technologies Corporation
19 May 2015
 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

Annual Meeting Statement

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, is holding its 2015 Annual Meeting at 11 a.m. (BST) today.

 

Tim Eggar, Chairman, will deliver the following statement to shareholders at the meeting.

 

"MYCELX is focused on its core commercial applications in regions where effective water treatment is critical to customers' ongoing operations. The Company continues to progress two major projects mentioned previously with trials now completed. The Directors anticipate that these projects will move into contract discussions. In addition, we have identified further turnaround projects in the Middle East that have approved budgets and new US onshore applications as targets for 2015 that will provide diversification to the advanced pipeline.

MYCELX is well positioned for turnaround projects which are short term, maintenance-driven and provide opportunity for quick media usage. These projects will support lease revenue streams as they are best addressed with modular, readily available equipment. MYCELX is ideally suited for these projects because of the flexible and effective way in which our media is deployed as well as the small footprint of our equipment and its ease of operation. Our successful completion of two turnaround projects this year highlights the continuing opportunities for the type of service required for reliable performance at our customers' operations.

 

However, we are operating in a sustained period of oil price volatility and this has resulted in slower deployment and less predictable expenditure of capital across the sector. As a result, predicting the timing of capital sales and revenue recognition continues to be difficult. Our current revenue projection is broadly in line with expectations but, as always, remains very dependent on the timing and successful completion of commercial negotiations.

 

Overall, MYCELX continues to see growing industry adoption of our technology. Wherever oil and gas production and petrochemical processing occurs, water is present and must be effectively treated. This is what MYCELX does best and where we will continue to move forward." 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO Tel: +1 888 306 6843

Mark Clark, CFO

 

Numis Securities Limited Tel: +44 20 7260 1000

Corporate Finance

John Prior

Paul Gillam

 

Corporate Broking

James Black

Ben Stoop

 

Bell Pottinger Tel: +44 20 3772 2500

Nick Lambert

Henry Lerwill

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMPKFDQKBKBNPD
Date   Source Headline
14th Mar 20234:50 pmRNSClosure of Restricted Stock Line
13th Feb 20237:00 amRNSOperational Update
31st Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSHalf Year Results Statement
15th Sep 20227:00 amRNSTrading Update
6th Sep 20222:30 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSNew Project Awards and Operations Update
13th Jul 20223:32 pmRNSResult of Annual Meeting
13th Jun 20227:00 amRNS2021 Annual Report & Notice of 2022 Annual Meeting
17th May 20227:00 amRNSFinal Results for Year Ending 31 December 2021
3rd May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSChange of Main Office Address
23rd Mar 20229:17 amRNSTR1
21st Mar 20225:56 pmRNSBroker Option
9th Mar 20207:00 amRNSClosure of Restricted Stock Line
5th Mar 20207:00 amRNSTrading Update
13th Dec 201910:25 amRNSBlock listing Interim Review
4th Nov 20197:00 amRNSTrading Update
16th Sep 20197:00 amRNSHalf Year Results Statement
20th Aug 201912:42 pmRNSHolding(s) in Company
16th Aug 20193:02 pmRNSDirector Shareholding
29th Jul 20197:00 amRNSDirectorate Changes
26th Jul 20197:00 amRNSAppointment of Nominated Adviser & Broker
22nd Jul 20191:34 pmRNSHolding(s) in Company
10th Jul 201912:57 pmRNSResult of Annual Meeting
14th Jun 20197:00 amRNSTrading Update
11th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20197:00 amRNSIssue of Equity
31st May 20191:57 pmRNSAnnual Financial Report
13th May 20197:00 amRNSFinal Results for the year ending 31 December 2018
28th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
27th Sep 20172:44 pmRNSApplication for Block Admission
26th Sep 20175:31 pmRNSClosure of Restricted Stock Line
21st Sep 20177:00 amRNSConsolidation of Stock Lines
13th Sep 20177:00 amRNSHalf Year Results Statement
12th Jul 201712:30 pmRNSResult of Annual Meeting
7th Jul 20177:00 amRNSHalf Year Trading Update
9th Jun 201710:00 amRNSMailing of Annual Financial Report & GM Notice
7th Jun 201710:30 amRNSBlock listing Interim Review
30th May 20171:19 pmRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSContract win with new SABIC affiliate customer
11th May 20177:00 amRNSFinal Results for the year ending 31 December 2016
8th May 20177:00 amRNSContract Award & Notification of Full Year Results
30th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmRNSBlock listing Interim Review
4th Oct 20167:00 amRNSAppointment of Nominated Adviser & Broker
14th Sep 20167:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.